Cardiac resynchronization therapy and atrial fibrillation

Cardiology Journal

Volumn 16, Issue 1, 2009, Pages 4-10

  Kamath, Ganesh S ^a   Steinberg, Jonathan S ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Atrial fibrillation; Cardiac resynchronization therapy

Indexed keywords

ANTIARRHYTHMIC AGENT;

ALGORITHM; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; REVIEW; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ALGORITHMS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HEART FAILURE; HEART RATE; HUMANS; PACEMAKER, ARTIFICIAL; TREATMENT OUTCOME;

EID: 60849135411     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol, 2003; 91: 2D-8D.
2. Steinberg JS. Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation. J Am Coll Cardiol, 2006; 48: 744-746.
3. Calkin H, Brugada J, Packer DL et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: A report of the Heart Rhythm Society (HRS) Task Force on Catheter Ablation of Atrial Fibrillation. Europace, 2007; 9: 335-379.
4. Fuster V, Ryden LE, Asinger RW et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: Executive summary. Circulation, 2001; 104: 2118-2150.
5. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. Circulation, 1991; 84: 40-48.
6. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol, 1998; 32: 695-703.
7. Wang TJ, Larson MG, Levy D et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation, 2003; 107: 2920-2925.
8. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med, 2001; 344: 873-880.
9. Cleland JGF, Daubert J-C, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005; 352: 1539-1549.
10. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 2004; 350: 2140-2150.
11. Young JB, Abraham WT, Smith AL et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA, 2003; 289: 2685-2694.
12. Leon AR, Greenberg JM, Kanuru N et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol, 2002; 39: 1258-1263.
13. Linde C, Leclercq C, Rex S et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol, 2002; 40: 111-118.
14. Molhoek SG, Bax JJ, Bleeker GB et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol, 2004; 94: 1506-1509.
15. Delnoy PP, Ottervanger JP, Luttikhuis HO et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol, 2007; 99: 1252-1257.
16. Koneru JN, Steinberg JS. Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure. Curr Opin Cardiol, 2008; 23: 9-15.
17. Melenovsky V, Hay I, Fetics BJ et al. Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy. Eur Heart J, 2005; 7: 637-638.
18. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: Part II. Pacing Clin Electrophysiol, 2006; 29: 70-96.
19. Kamath GS, Cotiga D, Koneru JN et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of non-responders following cardiac resynchronization therapy. Presented at Heart Rhythm Society Scientific Sessions, San Francisco 2007.
20. Carlson MD, Ip J, Messenger J et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol, 2003; 42: 627-633.
21. Padeletti L. Atrial fibrillation in heart failure patients implanted with a cardiac resynchronization therapy device: One-year results of the randomized MASCOT study. American Heart Association Scientific Sessions, Orlando 2007.
22. Doshi RN, Daoud EG, Fellows C at al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol, 2005; 16: 1160-1165.
23. Gasparini M, Auricchio A, Regoli F et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol, 2006; 48: 734-743.
24. Gasparini M AA, Marco M, Regoli F et al. For the MultiCenter Longitudinal Group. Long-term survival in patients undergoing cardiac resynchronization therapy: The importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J, 2008: 29; 1644-1652.
25. Ferreira A AP, Cavaco D, Cundeias R et al. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: The role of atrioventricular junction ablation. Europace, 2008; 10: 809-815.
26. Indik JH. Spontaneous conversion of atrial fibrillation in the setting of biventricular pacing. Cardiol Rev, 2004; 12: 1-2.
27. Hoppe UC, Casares JM, Eiskjaer H et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation, 2006; 114: 18-25.
28. Azpitarte J, Baun O, Moreno E, Garcia-Orta R, Sanchez-Ramos J, Tercedor L. In patients with chronic atrial fibrillation and left ventricular systolic dysfunction, restoration of sinus rhythm confers substantial benefit. Chest, 2001; 120: 132-138.
29. Butter C, Winbeck G, Schlegl M et al. Management of atrial fibrillation in cardiac resynchronization therapy clinical practice of CRT: How to improve the success rate. Eur Heart J, 2004; 6: D106-D111.
30. Corley SD, Epstein AE, DiMarco JP et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation, 2004; 109: 1509-1513.
31. Roy D, Talajic M, Nattel S et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med, 2008; 358: 2667-2677.
32. Earley MJ, Abrams DJR, Staniforth AD, Sporton SC, Schilling RJ. Catheter ablation of permanent atrial fibrillation: medium term results. Heart, 2006; 92: 233-238.
33. Lim TW, Jassal IS, Ross DL, Thomas SP. Medium-term efficacy of segmental ostial pulmonary vein isolation for the treatment of permanent and persistent atrial fibrillation. Pacing Clin Electrophysiol, 2006; 29: 374-379.
34. Chen MS, Marrouche NF, Khaykin Y et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol, 2004; 43: 1004-1009.
35. Hsu L-F, Jais P, Sanders P et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med, 2004; 351: 2373-2383.
36. Tondo C, Mantica M, Russo G et al. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol, 2006; 29: 962-970.
37. Gentlesk PJ, Sauer WH, Gerstenfeld EP et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol, 2007; 18: 9-14.
38. Choi AD HK, Vattakalam R, Mandava A et al. Pulmonary vein isolation results in improved ventricular function: A case-control study of patients with atrial fibrillation, heart failure and left ventricular dysfunction. American Heart Association Scientific Sessions, Orlando 2007.